PerformanceRiskValuationProfitabilityCashflowLiquidityESGRevenue & Geographic ExposureForecastFinancial GrowthIncome GrowthCashflow GrowthBalance Sheet Growth
503.87 - 512.55
344.79 - 555.45
23.62M / 20.39M (Avg.)
37.30 | 13.67
Shows the trajectory of a company's cash-generation capacity. Consistent growth in operating and free cash flow suggests a robust, self-funding business model—crucial for value investors seeking undervalued, cash-rich opportunities.
2.28%
Net income growth under 50% of ORCL's 42.29%. Michael Burry would suspect deeper structural issues in generating bottom-line growth.
2.56%
D&A growth well above ORCL's 0.20%. Michael Burry would suspect heavier depreciation burdens that might erode net income unless top-line follows suit.
181.52%
Well above ORCL's 38.41% if it’s a large positive yoy. Michael Burry would see a bigger future tax burden vs. competitor’s approach.
-3.70%
Negative yoy SBC while ORCL is 0.00%. Joel Greenblatt would see less immediate dilution advantage if talent levels remain strong.
-200.00%
Both reduce yoy usage, with ORCL at -235.90%. Martin Whitman would find an industry or cyclical factor prompting leaner operational approaches.
-207.25%
AR is negative yoy while ORCL is 0.00%. Joel Greenblatt would see a short-term cash advantage if revenue remains unaffected vs. competitor's approach.
No Data
No Data available this quarter, please select a different quarter.
No Data
No Data available this quarter, please select a different quarter.
-186.45%
Both reduce yoy usage, with ORCL at -235.90%. Martin Whitman would suspect an industry or cyclical factor pulling back on these items.
853.38%
Some yoy increase while ORCL is negative at -261.35%. John Neff would see competitor possibly reining in intangible charges or revaluations more effectively than we do.
-36.45%
Both yoy CFO lines are negative, with ORCL at -11.03%. Martin Whitman would suspect cyclical or cost factors harming the entire niche’s cash generation.
-37.18%
Negative yoy CapEx while ORCL is 58.70%. Joel Greenblatt would see a near-term FCF boost unless competitor invests for long-term advantage.
No Data
No Data available this quarter, please select a different quarter.
-21.10%
Both yoy lines negative, with ORCL at -33.76%. Martin Whitman would suspect an environment with fewer attractive securities or a strategic pivot to internal growth.
93.92%
We have some liquidation growth while ORCL is negative at -1.38%. John Neff notes a short-term liquidity advantage if competitor is holding or restricted.
-143.38%
We reduce yoy other investing while ORCL is 0.00%. Joel Greenblatt sees a near-term cash advantage unless competitor’s intangible or side bets produce strong returns.
-30.75%
Both yoy lines negative, with ORCL at -1133.33%. Martin Whitman suspects a broader cyclical shift away from heavy investing across the niche.
-375000.00%
We cut debt repayment yoy while ORCL is 0.00%. Joel Greenblatt sees competitor possibly lowering risk more if expansions do not hamper them.
25.44%
Lower share issuance yoy vs. ORCL's 305.19%, implying less dilution. David Dodd would confirm the firm still has enough capital for expansions.
-22.22%
We cut yoy buybacks while ORCL is 80.29%. Joel Greenblatt would question if competitor is gaining a per-share edge unless expansions justify holding cash here.